OTLC insider transaction filings
Oncotelic Therapeutics, Inc. — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-23. Screen OTLC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | Fein Seymour Howard — CRO/CMO | Grant/award (A): 250 (derivative) @ $0 | EDGAR |
| 2026-07-21 | 4 | KING STEVEN W — Director | Grant/award (A): 250 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Saund Saran — CBO | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Shah Amit B. — CFO | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | MAIDA ANTHONY E III — DIRECTOR AND CMO - TRANS. MED., Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Purchase (P): 240,000 @ $0.04 | EDGAR |
| 2026-06-24 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Purchase (P): 115,000 @ $0.04 · Purchase (P): 75,000 @ $0.04 · Purchase (P): 65,000 @ $0.04 | EDGAR |
| 2026-06-22 | 4 | Shah Amit B. — CFO | Purchase (P): 20,000 @ $0.05 | EDGAR |
| 2026-06-17 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Purchase (P): 239,759 @ $0.04 · Purchase (P): 96,000 @ $0.04 | EDGAR |
| 2026-01-26 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Grant/award (A): 4,426 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Grant/award (A): 4,065 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Purchase (P): 104,000 @ $0.01 · Purchase (P): 1 @ $0.01 · Purchase (P): 94,736 @ $0.01 | EDGAR |
| 2025-01-31 | 4 | Trieu Vuong — CHAIRMAN AND CEO, Director, 10% owner | Purchase (P): 183,066 @ $0.03 · Purchase (P): 100,003 @ $0.03 · Purchase (P): 63,775 @ $0.03 | EDGAR |
Recent 8-K events — Oncotelic Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OTLC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →